Crown Reserve Acquisition Corp. I recently announced a major transaction, valuing Carvix at an implied enterprise value of 1 billion dollars.

After the completion of the transaction, the newly formed merged company will seek to be listed on the Nasdaq Stock Exchange. This transaction not only highlights the market’s strong recognition of Carvix’s business potential, but also provides the merged entity with access to a new capital platform. By entering Nasdaq, the company is expected to attract broader investor attention and liquidity support, injecting strong momentum for future growth.